Hyperparathyroidism Clinical Trials

A listing of Hyperparathyroidism medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Florida

UPDATED

Orlando Florida 32806

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Kentucky

Louisville Kentucky 40202

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Louisiana

UPDATED

New Orleans Louisiana 70112

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Minnesota

UPDATED

Minneapolis Minnesota 55454

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Missouri

Kansas City Missouri 64108

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

New Jersey

UPDATED

Hackensack New Jersey 07601

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

New York

UPDATED

New York New York 10029-6574

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Oregon

UPDATED

Portland Oregon 97227

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Wisconsin

UPDATED

Marshfield Wisconsin 54449

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Argentina

UPDATED

San Miguel De Tucuman 4107

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

Belgium

Brussels 1020

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Ghent 9000

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Leuven 3000

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Chile

UPDATED

Santiago 838-0418

A clinical research study of Doxercalciferol (GZ427397) and Calcitriol for the treatment of Secondary Hyperparathyroidism-Chronic Kidney Disease

China

Nanjing Jiangsu 210002

A clinical research study of Cinacalcet HCl for the treatment of Hyperparathyroidism; Secondary, Renal

Germany

Cologne 50937

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Hanover 30625

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Heidelberg 69120

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Marburg 35043

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Italy

San Fermo della battaglia (CO) 22020

A clinical study for patients with Hyperparathyroidism, Secondary

Japan

Ōsaka

A clinical trial to evaluate treatments using KHK7580 for patients with Parathyroid Carcinoma or Primary Hyperparathyroidism

Tokyo

A clinical trial to evaluate treatments using KHK7580 for patients with Secondary Hyperparathyroidism

Tokyo

Patients are needed to participate in a clinical research study of KHK7580 to evaluate Secondary Hyperparathyroidism

Lithuania

Vilinus 08406

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

Poland

Krakow 30-663

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism

United Kingdom

London WC1N 3JH

A clinical research study of Study Drug for the treatment of Chronic Kidney Disease, Secondary Hyperparathyroidism